Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Sorensen P S, Lycke J, Erälinna J-P, Edland A, Wu X, Frederiksen J L, Oturai A, Malmeström C, Stenager E, Sellebjerg F, et al.